Respiratory Tract Diseases

568 trials 207 recruiting

Filter these 568 trials by phase, country and sponsor.

Open in Search →

Clinical trial of MDNA11 (investigational drug) administered alone or in combination with pembrolizumab (immune checkpoint inhibitor) in Pat… Recruiting

2023-507536-21-00 Advanced Solid Tumors 7 2024-10-04
A study of different investigational treatments in people with the interstitial lung disease that accompanies scleroderma (CONQUEST) Recruiting

2023-507129-40-00 interstitial lung disease secondary to systemic scleros 4 2024-08-06
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis Recruiting

2023-503699-25-00 Progressive Pulmonary Fibrosis 5 2024-07-15
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis Recruiting

2023-503697-21-01 Idiopathic pulmonary fibrosis 5 2024-06-24
Pragmatic trial on the safety and tolerability of an optimized dose of rifampicin in tuberculosis patients Recruiting

2023-509885-39-00 Tuberculosis 5 2024-01-15
Safety and effect of mesenchymal derived Extracellular Vesicles in the prevention of Bronchopulmonary Dysplasia in extremely preterm newborn… Recruiting

2022-500293-34-01 Bronchopulmonary Dysplasia 7 2023-12-28
Safety and efficacy of anakinra treatment for patients with persistent respiratory symptoms post acute covid and immune system activation: t… Recruiting

2023-508123-12-00 Post-Acute COVID Syndrome (PACS) 10 2023-11-03
Clairleaf TM: A study to test long-term treatment with BI 1291583 in people with bronchiectasis who took part in a previous study with this … Recruiting

2023-503290-38-00 Bronchiectasis 4 2023-09-05
OLE study in participants with pulmonary arterial hypertension Recruiting

2023-505539-11-00 Pulmonary Arterial Hypertension 10 2023-04-06
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA). Recruiting

2023-507031-38-00 Severe viral lung infections 5 2023-01-09
Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels (ADAPT ALEC) Recruiting

2023-506886-76-00 ALK positive non-small cell lung cancer 6 2022-03-23
A randomised, open-label, single-centre, drug-drug-interaction trial to evaluate the impact of carboxylesterase 2 (CES2)- and CYP3A4-inhibit… Recruiting

2026-526135-18-00 Idiopathic pulmonary fibrosis 3 2026-05-12
A Study to evaluate the long-term safety and tolerability of tozorakimab in patients with chronic obstructive pulmonary disease (COPD) and a… Recruiting

2025-523690-41-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2026-05-04
A Phase 1b, Double-Blind Study to Investigate Safety, Tolerability, Pharmacokinetics, Efficacy, and Pharmacodynamics of Single Dose of ATI-0… Recruiting

2025-524987-39-00 Mild to Moderate Asthma 3 2026-05-04
COMMODITIES : Comparison of initial dual oral COMbination therapy to MOnotherapy in pulmonary arterial hypertension with cardiovascular como… Recruiting

2023-509891-40-00 Pulmonary arterial hypertension 5 2026-04-28
PIPELINE-RSV-France Recruiting

2025-521755-23-00 Respiratory syncytial virus infection 5 2026-04-28
Inhaled isoflurane for SEdation of invasively ventilated PaTIents with cardiogenic shock on extracOrporeal membrane oxygeNation (INSEPTION) Recruiting

2023-510261-94-00 Adult patients with severe cardiogenic shock on venoart 5 2026-04-26
Therapeutic equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in subjects with mild to moderate asthma (TRECONY) Recruiting

2025-521456-35-00 Mild to moderate asthma 4 2026-04-13
Exploring the anti-aging effects of Metformin in COPD Recruiting

2025-520972-24-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2026-04-08
A study to test whether nerandomilast can help slow down changes in the lung in people with a family history of pulmonary fibrosis Recruiting

2025-522383-33-00 Interstitial lung diseases 5 2026-03-23
Apneic oxygenation with high-flow nasal oxygenation after preoxygenation with noninvasive ventilation before intubation in hypoxemic patient… Recruiting

2024-514949-11-00 Hypoxemic acute respiratory failure 5 2026-03-18
A Phase 1 study to evaluate the effect of BV100 on the pharmacokinetics of polymyxin B in healthy volunteers Recruiting

2025-521020-30-00 Healthy volunteer trial. Intended indication: treatment 3 2026-03-12
A Study to Investigate Using Inhaled Fexlamose to Treat Adult Participants Who Have Moderate to Severe COPD Recruiting

2025-523020-50-00 Chronic Obstructive Pulmonary Disease 4 2026-03-04
Does the Length of Surfactant Treatment Affect How Well Very Premature Babies Stabilize? – Comparing 1-Minute and 5-Minute Methods Recruiting

2025-522754-39-00 Neonatal respiratory distress syndrome 6 2026-02-24